Movement Alert|Guardant Health Inc. Intraday Rise 6.64% in Regular Trading, Q3 Beat and Higher Revenue Outlook Support Sentiment

Market Focus11-10

On November 10, Guardant Health Inc. rose 6.64% in Regular Trading, trading at $160.295 per share, with turnover of $178 million.

The clearest catalyst in recent public disclosures is the company’s third-quarter earnings beat and higher full-year revenue outlook, which helped refocus investors on operating momentum.

Guardant Health Inc. reported adjusted Q3 loss of $0.29 per share, better than market expectations of a $0.31 loss, while revenue rose to $361 million from $265.2 million a year earlier and exceeded expectations of about $350.7 million. The company also lifted full-year revenue guidance to $1.36 billion-$1.37 billion from $1.34 billion-$1.36 billion. Offsetting that, it now expects full-year free cash flow burn of $205 million-$220 million, above its prior outlook of $195 million-$205 million. Recent coverage of the stock’s advance indicated short-term trading was being supported mainly by the revenue beat and improved guidance, despite ongoing litigation-related cost pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment